GLP-_European Financial Times

Location： Home- Tag Cloud- GLP-

HSBC Downgrades Novo Nordisk (NVO.US) Rating to "Hold" with 2025 Growth Expectations Cut

We have learned from HSBC that it has downgraded its rating on Novo Nordisk (NVO.US) from \"Buy\" to \"Hold\", citing the company\'s latest warning on its business outlook for 2025. The management of

Breaking News drugmarket GLP-growthexpectationscut HSBC NovoNordisk ratingdowngrade stockpricepressure 1 days ago 0 1.2k
NVO-US: A Turning Point? Market Overreaction or GLP-1 Myth Come to an End?

Zhitong Caifu APP has learned that Danish pharmaceutical giant Novo Nordisk (NVO.US) plummeted nearly 30% in recent days, sparking market shockwaves, with its year-to-date decline exceeding 60%. This

Breaking News biopharmaceutical competitivepressure GLP-investorsentiment markettrends NovoNordisk Ozempic pharmaceuticalindustry stockprice valuation Wegovy 2 days ago 0 1.7k
Stone Pharmaceutical: Enters into Exclusive Licensing Agreement with Madrigal for SYH2086, Reserving Right to Receive Up to $207.5 Million Total Payment

　　Global Times July 30th ｜ Stone Pharmaceutical (01093.HK) announced that the company has entered into an exclusive licensing agreement with Madrigal Pharmaceuticals, Inc. for the global developmen

Breaking News GLP-Licensingagreement MadrigalPharmaceuticals receptoragonist StonePharmaceutical SyH 3 days ago 0 1.9k
Shanxi Pharmaceutical Group (01093) and Madrigal Reach Exclusive Authorization Agreement for SYH2086

Citicape Financial APP News, Shanxi Pharmaceutical Group (01093) released an announcement, stating that the group has reached an exclusive authorization agreement with Madrigal Pharmaceuticals, Inc. (

Breaking News exclusiveauthorizationagreement GLP-MadrigalPharmaceuticals receptoragonist ShanxiPharmaceuticalGroup SyH 3 days ago 0 1.6k
McGregor: Mingshan Kantor's interim results exceed expectations, reaffirming target price of HK$116

McGregor released a research report, reaffirming Mingshan Kantor (02359) with a \"beats the market\" rating and a target price of HK$116. The firm stated that Mingshan Kantor\'s interim results exceed

International GLP-grossmargin HK interimresults McGregor MingshanKantor netprofit rawmaterials revenue targetprice TIDES 4 days ago 0 1k

HSBC Downgrades Novo Nordisk (NVO.US) Rating to "Hold" with 2025 Growth Expectations Cut

NVO-US: A Turning Point? Market Overreaction or GLP-1 Myth Come to an End?

Stone Pharmaceutical: Enters into Exclusive Licensing Agreement with Madrigal for SYH2086, Reserving Right to Receive Up to $207.5 Million Total Payment

Shanxi Pharmaceutical Group (01093) and Madrigal Reach Exclusive Authorization Agreement for SYH2086

McGregor: Mingshan Kantor's interim results exceed expectations, reaffirming target price of HK$116

TCL Exhibits at 2025 ChinaJoy, Showcasing Comprehensive Gaming Display Products and Intelligent Terminals

2025 ChinaJoy Qualcomm Pavilion Unveiled, Showcasing Over 100 Terminal Games

Ideal Automobile: 19 New Stores Added in July, Total Retail Centers Reach 535

Ayita July Sales Volume Hits 10,062 Units, Up 178% Year-on-Year

Honda to Invest $2000 Million in Turkey to Build Motorcycle Factory, Production to Start in Mid-2026

Jinan Launches Second Round of 12 Million Yuan Automotive Consumption Subsidy in the Second Half of the Year

SVB Raises Tesla's Stock Target Price to $5.4 Amid New Model L90 Boost

Qoros Announces Solid-State Battery and Manufacturing Method Patent

Rongtu Automobile Delivers 12,135 Vehicles in July, a 102% Increase Year-on-Year

Rongan Automobile: Delivers 12,135 vehicles in July, a year-on-year increase of 102%

Riding-Powered Cars: July Deliveries Reach a Record High of 50,129 Units, with a Year-on-Year Growth of Over 126%! This Marks Riding-Powered Cars' First Time Breaking Through the 50,000-Unit Mark in Monthly Sales!

Safeguarding Life: "Safety Isn't Just an Empty Ideal, It's Our Actual Guardian!" Don't Treat Life Like a Lab Experiment!